Purchase Order 75N94020P00560
Award Date 7/31/20
Potential Completion Date 7/30/21
Potential Value $66K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $13,936.77 firm fixed price purchase order to Genscript USA Inc. for gene synthesis services. The place of performance is Bethesda, Maryland. The one-year contract runs from August 17, 2023 through August 16, 2024 to support NICHD's research programs. As a leading biotechnology company, Genscript will leverage its expertise in gene engineering to deliver customized genetic material and...
- This is a $14,500 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for NICHD laboratory services and does not have a set-aside designation. Genscript is a provider of a wide range of molecular biology products and services to federal agencies, including gene...
- This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...
- The National Institute of Child Health and Human Development (NICHD) awarded a $20,000 firm fixed price Blanket Purchase Agreement (BPA) call to Genscript USA Inc. for customized gene synthesis services. This contract, issued on July 1, 2014, with an ultimate completion date of June 30, 2015, represents a non-set-aside award to the Piscataway, New Jersey-based biotechnology firm. The work will be performed at Genscript's facility in Piscataway, NJ 08854. Genscript USA Inc. is a specialized...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,141.84 purchase order to Genscript USA Inc. for "OTHER FUNCTIONS - CUSTOMIZED GENE SYNTHESES" to be performed in Bethesda, Maryland between September 8-16, 2016. As a firm fixed price contract for customized gene synthesis services, Genscript will deliver specified genetic material to the NIH organization to support its biomedical...
- The National Institute of Child Health and Human Development (NICHD) awarded a Blanket Purchase Agreement (BPA) call order to GenScript USA Inc. valued at $24,500 on July 20, 2018, with an ultimate completion date of July 19, 2019. This firm fixed-price contract, which utilized no set-aside designation, represents a task order against an existing BPA vehicle and is to be performed in Bethesda, Maryland. GenScript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey,...
- GenScript USA Inc. was awarded an $8,500 firm fixed price BPA call by the National Institute of Child Health and Human Development (NICHD) on September 24, 2014, with an ultimate completion date of June 30, 2015. The contract was executed without a set-aside designation and represents a task order against an existing blanket purchase agreement. Performance is scheduled to take place in Bethesda, Maryland. As a biotechnology company specializing in advanced molecular biology services, GenScript...
- This federal contract award, valued at $4,367.10, was issued by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for a firm fixed-price purchase order with a completion date of September 30, 2014. Genscript, which operates as a for-profit organization, has received numerous prime and subcontract awards from various Department of Health and Human Services (HHS) agencies, including...